General Information of Drug Transporter (DT)
DT ID DTD0519 Transporter Info
Gene Name CACNA1B
Transporter Name Voltage-gated calcium channel alpha Cav2.2
Gene ID
774
UniProt ID
Q00975
Post-Translational Modification of This DT
Overview of CACNA1B Modification Sites with Functional and Structural Information
Sequence
MVRFGDELGG RYGGPGGGER ARGGGAGGAG GPGPGGLQPG QRVLYKQSIA QRARTMALYN 
PIPVKQNCFT VNRSLFVFSE DNVVRKYAKR ITEWPPFEYM ILATIIANCI VLALEQHLPD 
GDKTPMSERL DDTEPYFIGI FCFEAGIKII ALGFVFHKGS YLRNGWNVMD FVVVLTGILA 
TAGTDFDLRT LRAVRVLRPL KLVSGIPSLQ VVLKSIMKAM VPLLQIGLLL FFAILMFAII 
GLEFYMGKFH KACFPNSTDA EPVGDFPCGK EAPARLCEGD TECREYWPGP NFGITNFDNI 
LFAILTVFQC ITMEGWTDIL YNTNDAAGNT WNWLYFIPLI IIGSFFMLNL VLGVLSGEFA 
KERERVENRR AFLKLRRQQQ IERELNGYLE WIFKAEEVML AEEDRNAEEK SPLDVLKRAA 
TKKSRNDLIH AEEGEDRFAD LCAVGSPFAR ASLKSGKTES SSYFRRKEKM FRFFIRRMVK 
AQSFYWVVLC VVALNTLCVA MVHYNQPRRL TTTLYFAEFV FLGLFLTEMS LKMYGLGPRS 
YFRSSFNCFD FGVIVGSVFE VVWAAIKPGS SFGISVLRAL RLLRIFKVTK YWSSLRNLVV 
SLLNSMKSII SLLFLLFLFI VVFALLGMQL FGGQFNFQDE TPTTNFDTFP AAILTVFQIL 
TGEDWNAVMY HGIESQGGVS KGMFSSFYFI VLTLFGNYTL LNVFLAIAVD NLANAQELTK 
DEEEMEEAAN QKLALQKAKE VAEVSPMSAA NISIAARQQN SAKARSVWEQ RASQLRLQNL 
RASCEALYSE MDPEERLRFA TTRHLRPDMK THLDRPLVVE LGRDGARGPV GGKARPEAAE 
APEGVDPPRR HHRHRDKDKT PAAGDQDRAE APKAESGEPG AREERPRPHR SHSKEAAGPP 
EARSERGRGP GPEGGRRHHR RGSPEEAAER EPRRHRAHRH QDPSKECAGA KGERRARHRG 
GPRAGPREAE SGEEPARRHR ARHKAQPAHE AVEKETTEKE ATEKEAEIVE ADKEKELRNH 
QPREPHCDLE TSGTVTVGPM HTLPSTCLQK VEEQPEDADN QRNVTRMGSQ PPDPNTIVHI 
PVMLTGPLGE ATVVPSGNVD LESQAEGKKE VEADDVMRSG PRPIVPYSSM FCLSPTNLLR 
RFCHYIVTMR YFEVVILVVI ALSSIALAAE DPVRTDSPRN NALKYLDYIF TGVFTFEMVI 
KMIDLGLLLH PGAYFRDLWN ILDFIVVSGA LVAFAFSGSK GKDINTIKSL RVLRVLRPLK 
TIKRLPKLKA VFDCVVNSLK NVLNILIVYM LFMFIFAVIA VQLFKGKFFY CTDESKELER 
DCRGQYLDYE KEEVEAQPRQ WKKYDFHYDN VLWALLTLFT VSTGEGWPMV LKHSVDATYE 
EQGPSPGYRM ELSIFYVVYF VVFPFFFVNI FVALIIITFQ EQGDKVMSEC SLEKNERACI 
DFAISAKPLT RYMPQNRQSF QYKTWTFVVS PPFEYFIMAM IALNTVVLMM KFYDAPYEYE 
LMLKCLNIVF TSMFSMECVL KIIAFGVLNY FRDAWNVFDF VTVLGSITDI LVTEIAETNN 
FINLSFLRLF RAARLIKLLR QGYTIRILLW TFVQSFKALP YVCLLIAMLF FIYAIIGMQV 
FGNIALDDDT SINRHNNFRT FLQALMLLFR SATGEAWHEI MLSCLSNQAC DEQANATECG 
SDFAYFYFVS FIFLCSFLML NLFVAVIMDN FEYLTRDSSI LGPHHLDEFI RVWAEYDPAA 
CGRISYNDMF EMLKHMSPPL GLGKKCPARV AYKRLVRMNM PISNEDMTVH FTSTLMALIR 
TALEIKLAPA GTKQHQCDAE LRKEISVVWA NLPQKTLDLL VPPHKPDEMT VGKVYAALMI 
FDFYKQNKTT RDQMQQAPGG LSQMGPVSLF HPLKATLEQT QPAVLRGARV FLRQKSSTSL 
SNGGAIQNQE SGIKESVSWG TQRTQDAPHE ARPPLERGHS TEIPVGRSGA LAVDVQMQSI 
TRRGPDGEPQ PGLESQGRAA SMPRLAAETQ PVTDASPMKR SISTLAQRPR GTHLCSTTPD 
RPPPSQASSH HHHHRCHRRR DRKQRSLEKG PSLSADMDGA PSSAVGPGLP PGEGPTGCRR 
ERERRQERGR SQERRQPSSS SSEKQRFYSC DRFGGREPPK PKPSLSSHPT SPTAGQEPGP 
HPQGSGSVNG SPLLSTSGAS TPGRGGRRQL PQTPLTPRPS ITYKTANSSP IHFAGAQTSL 
PAFSPGRLSR GLSEHNALLQ RDPLSQPLAP GSRIGSDPYL GQRLDSEASV HALPEDTLTF 
EEAVATNSGR SSRTSYVSSL TSQSHPLRRV PNGYHCTLGL SSGGRARHSY HHPDQDHWC
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

256

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at CACNA1B Asparagine 256 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

1563

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at CACNA1B Asparagine 1563 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1B [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

1675

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at CACNA1B Asparagine 1675 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

68

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at CACNA1B Cystine 68 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        33 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

411

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 411 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

455

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 455 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1B [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

460

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 460 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNA1B [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

745

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 745 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence CACNA1B [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

748

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 748 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence CACNA1B [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

753

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 753 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence CACNA1B [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

761

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 761 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence CACNA1B [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

766

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 766 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence CACNA1B [3] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

783

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 783 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence CACNA1B [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

876

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 876 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence CACNA1B [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

923

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 923 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence CACNA1B [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1134

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 1134 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence CACNA1B [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1783

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 1783 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence CACNA1B [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1793

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 1793 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence CACNA1B [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1916

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 1916 has the potential to affect its expression or activity.

  PTM Phenomenon 16

Have the potential to influence CACNA1B [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1917

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 1917 has the potential to affect its expression or activity.

  PTM Phenomenon 17

Have the potential to influence CACNA1B [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1919

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 1919 has the potential to affect its expression or activity.

  PTM Phenomenon 18

Have the potential to influence CACNA1B [9] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1960

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 1960 has the potential to affect its expression or activity.

  PTM Phenomenon 19

Have the potential to influence CACNA1B [16]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1968

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 1968 has the potential to affect its expression or activity.

  PTM Phenomenon 20

Have the potential to influence CACNA1B [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2001

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2001 has the potential to affect its expression or activity.

  PTM Phenomenon 21

Have the potential to influence CACNA1B [9] , [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2016

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2016 has the potential to affect its expression or activity.

  PTM Phenomenon 22

Have the potential to influence CACNA1B [17] , [19]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2023

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2023 has the potential to affect its expression or activity.

  PTM Phenomenon 23

Have the potential to influence CACNA1B [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2129

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2129 has the potential to affect its expression or activity.

  PTM Phenomenon 24

Have the potential to influence CACNA1B [9] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2208

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2208 has the potential to affect its expression or activity.

  PTM Phenomenon 25

Have the potential to influence CACNA1B [9] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2209

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2209 has the potential to affect its expression or activity.

  PTM Phenomenon 26

Have the potential to influence CACNA1B [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2219

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2219 has the potential to affect its expression or activity.

  PTM Phenomenon 27

Have the potential to influence CACNA1B [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2224

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2224 has the potential to affect its expression or activity.

  PTM Phenomenon 28

Have the potential to influence CACNA1B [9] , [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2233

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2233 has the potential to affect its expression or activity.

  PTM Phenomenon 29

Have the potential to influence CACNA1B [9] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2256

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2256 has the potential to affect its expression or activity.

  PTM Phenomenon 30

Have the potential to influence CACNA1B [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2266

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2266 has the potential to affect its expression or activity.

  PTM Phenomenon 31

Have the potential to influence CACNA1B [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2295

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2295 has the potential to affect its expression or activity.

  PTM Phenomenon 32

Have the potential to influence CACNA1B [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2298

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2298 has the potential to affect its expression or activity.

  PTM Phenomenon 33

Have the potential to influence CACNA1B [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2299

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Serine 2299 has the potential to affect its expression or activity.

  Threonine

        17 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [20]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

176

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 176 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [20]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

181

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 181 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1B [21]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

421

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 421 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNA1B [22]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1085

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 1085 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence CACNA1B [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1136

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 1136 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence CACNA1B [17]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1584

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 1584 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence CACNA1B [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1788

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 1788 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence CACNA1B [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1792

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 1792 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence CACNA1B [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1794

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 1794 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence CACNA1B [15] , [17]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1918

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 1918 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence CACNA1B [8] , [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1961

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 1961 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence CACNA1B [19]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

2024

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 2024 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence CACNA1B [23]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

2193

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 2193 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence CACNA1B [9] , [18]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

2205

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 2205 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence CACNA1B [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

2218

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 2218 has the potential to affect its expression or activity.

  PTM Phenomenon 16

Have the potential to influence CACNA1B [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

2294

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 2294 has the potential to affect its expression or activity.

  PTM Phenomenon 17

Have the potential to influence CACNA1B [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

2301

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Threonine 2301 has the potential to affect its expression or activity.

  Tyrosine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

463

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Tyrosine 463 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [24]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1493

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Tyrosine 1493 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1B [25]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1736

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Tyrosine 1736 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNA1B [26]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

2128

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Tyrosine 2128 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence CACNA1B [26]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

2259

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Tyrosine 2259 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence CACNA1B [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

2296

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B Tyrosine 2296 has the potential to affect its expression or activity.

  Unclear Residue

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [27]

Role of PTM

Potential impacts

Related Enzyme

Protein kinase C alpha type (PRKCA)
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNA1B has the potential to affect its expression or activity.

Ubiquitination

  Alanine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [28]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

1336

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Alanine 1336 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

1768

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Alanine 1768 has the potential to affect its expression or activity.

  Arginine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Arginine

Modified Location

1769

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Arginine 1769 has the potential to affect its expression or activity.

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

1766

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Cystine 1766 has the potential to affect its expression or activity.

  Glutamicacid

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [28]

Role of PTM

Potential impacts

Modified Residue

Glutamicacid

Modified Location

1330

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Glutamicacid 1330 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [30]

Role of PTM

Potential impacts

Modified Residue

Glutamicacid

Modified Location

1332

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Glutamicacid 1332 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1B [28]

Role of PTM

Potential impacts

Modified Residue

Glutamicacid

Modified Location

1335

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Glutamicacid 1335 has the potential to affect its expression or activity.

  Glycine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

1763

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Glycine 1763 has the potential to affect its expression or activity.

  Isoleucine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [28]

Role of PTM

Potential impacts

Modified Residue

Isoleucine

Modified Location

1247

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Isoleucine 1247 has the potential to affect its expression or activity.

  Leucine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [28]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

1253

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Leucine 1253 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

1762

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Leucine 1762 has the potential to affect its expression or activity.

  Lysine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

201

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Lysine 201 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [18]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

417

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Lysine 417 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNA1B [28]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1248

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Lysine 1248 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNA1B [28] , [30]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1331

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Lysine 1331 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence CACNA1B [31]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1447

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Lysine 1447 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1764

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Lysine 1764 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1765

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Lysine 1765 has the potential to affect its expression or activity.

  Proline

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [30]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

1448

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Proline 1448 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Proline

Modified Location

1767

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Proline 1767 has the potential to affect its expression or activity.

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [30]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1249

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Serine 1249 has the potential to affect its expression or activity.

  Valine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNA1B [28]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

1252

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Valine 1252 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNA1B [29]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

1770

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at CACNA1B Valine 1770 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: CAC1B_HUMAN)
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov;14(11):1166-72.
4 Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48.
5 Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS. Anal Chem. 2017 Sep 5;89(17):8853-8862.
6 Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
7 Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics. 2015 Jan;15(2-3):500-7.
8 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
9 Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
10 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
11 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
12 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
13 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
14 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
15 Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
16 Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column. Anal Sci. 2008 Jan;24(1):161-6.
17 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
18 Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
19 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
20 Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
21 Cross-talk between G-protein and protein kinase C modulation of N-type calcium channels is dependent on the G-protein beta subunit isoform. J Biol Chem. 2000 Dec 29;275(52):40777-81.
22 Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46.
23 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
24 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
25 Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
26 Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
27 UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. (ID: Q00975)
28 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
29 Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
30 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
31 New findings on essential amino acids. Cesk Fysiol. 1990;39(1):13-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.